ABVX vs ALGN
Abivax S.A. vs Align Technology — AI-powered side-by-side comparison
VS
ALGN
Align Technology
73
Buy
| Metric | ABVX | ALGN |
|---|
| AI Score |
61
|
73
|
| Price |
$126.75
|
$172.86
|
| P/E Ratio |
-22.77×
|
30.03×
|
| ROE |
-73.9%
|
10.1%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
0.0%
|
66.5%
|
| Debt / Equity |
0.10×
|
0.03×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
47.8
|
55.1
|
| Beta |
-0.226
|
1.653
|
| Expected Upside |
—
|
+7.7%
|
AI Committee View
Current Innellis committee reasoning for ABVX versus ALGN.
ALGN leads by 12 points.
ALGN scores 73/100 (Buy) versus ABVX at 61/100 (Buy).
ABVX Committee View
60% agreement
5 analysts
Positive signals support the current rating — vix regime is low -- calm backdrop supports risk-taking. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Price-to-book of 19.9x prices in significant intangible value — Value
- ROE of only -51.7% -- cheap may mean cheap for a reason — Value
- MACD histogram negative -- bearish momentum — Technical
ALGN Committee View
100% agreement
5 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.